L'intérêt à découvert pour Instil Bio donne aux investisseurs une idée du degré auquel les investisseurs parient sur la baisse de l'action de Instil Bio. Les données sur l'intérêt à découvert sont mises à jour toutes les deux semaines.

Instil Bio (NASDAQ:TIL) Stock, Rapport sur les intérêts à découvert

Instil Bio

Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize FRα, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.

Instil Bio Inc

Till Capital Corp

Interface Inc

Listed Funds Trust Teucrium Agricultural Strategy No K-1 ETF

FlexShares Mornigstar US Market Factors Tilt Index Fund ETF

In the current market session, Select Medical Hldgs Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SEM#NYSE">SEM</a>) share price is at $18.73, after a 0.48% increase. Moreover, over the past month, the stock decreased by 5.59%, but in the past year, spiked by 31.69%. Shareholders might be interested in knowing whether the stock is overvalued, even if the company is performing up to par in the current session. 

<img src="https://www.benzinga.com/files/images/story/2025/1736450112_0.png" alt="Past Year Chart" />

<h3>Select Medical Hldgs P/E Compared to Competitors</h3>
The P/E ratio is used by long-term shareholders to assess the company's market performance against aggregate market data, historical earnings, and the industry at large. A lower P/E could indicate that shareholders do not expect the stock to perform better in the future or it could mean that the company is undervalued. 
Compared to the aggregate P/E ratio of the 25.68 in the Health Care Providers &amp; Services industry, Select Medical Hldgs Inc. has a lower P/E ratio of 8.75. Shareholders might be inclined to think that the stock might perform worse than it's industry peers. It's also possible that the stock is undervalued. 

<img src="https://www.benzinga.com/files/images/story/2025/1736450112_1.png" alt="Guage" />

In conclusion, the price-to-earnings ratio is a useful metric for analyzing a company's market performance, but it has its limitations. While a lower P/E can indicate that a company is undervalued, it can also suggest that shareholders do not expect future growth. Additionally, the P/E ratio should not be used in isolation, as other factors such as industry trends and business cycles can also impact a company's stock price. Therefore, investors should use the P/E ratio in conjunction with other financial metrics and qualitative analysis to make informed investment decisions.

News

Intraday Update

Markets

Price Over Earnings Overview: Select Medical Hldgs

<a href="https://www.ft.com/content/38c519c3-1fe9-4d2c-9d8c-6dd158ab35aa" title="https://www.ft.com/content/38c519c3-1fe9-4d2c-9d8c-6dd158ab35aa">https://www.ft.com/content/38c519c3-1fe9-4d2c-9d8c-6dd158ab35aa</a>

Politics

General

OKLO

Report From Jan. 3 "US relaxes green hydrogen rules in race to boost sector" -Financial Times

According to JP Morgan, U.S. large-cap biopharma stocks have underperformed the broader market for two consecutive years, with mixed sentiment shaping <a target="_blank" href="https://www.benzinga.com/24/12/42638844/large-biopharma-lags-market-jp-morgans-2025-outlook-on-eli-lilly-merck-and-more" rel="noreferrer noopener">investor outlook for 2025</a>.
Despite strong fundamentals and advancements in drug pipelines, factors such as political uncertainty and sector rotation have hindered the sector&#8217;s performance relative to the S&amp;P 500.
In 2024, biopharma stocks rose by 9.6%, falling short of the S&amp;P 500&#8217;s 28.5% surge. However, JP Morgan analysts maintain a positive outlook for several key players.
Ahead of the 2025 JPM Healthcare Conference, JP Morgan highlights some investor expectations as sentiment remains mixed for the US Large Cap BioPharma group heading into 2025. The conference is scheduled between 13 January and 16 January.
Obesity is expected to remain a major focus for the industry. The sector&#8217;s focus on the below advancements highlights the growing importance of obesity treatments and related drug innovations:
<ul>
<li>Eli Lilly And Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LLY#NYSE">LLY</a>): Increased emphasis on incretin therapies as production capacity grows and direct-to-consumer advertising gains traction. Key data catalysts: Phase 3 results for orforglipron, an oral <a href="https://www.benzinga.com/general/biotech/23/07/33339766/ozempic-alternatives-these-two-drugs-show-promise-in-affordability-and-effectiveness-for-weight-l" target="_blank" rel="noreferrer noopener">small molecule GLP-1</a>.</li>
<li>Initial outcomes data for tirzepatide <a href="https://www.benzinga.com/general/biotech/24/08/40460727/eli-lillys-famed-obesitydiabetes-treatment-tirzepatide-shows-potential-to-cut-risk-of-developing-" target="_blank" rel="noreferrer noopener">in type 2 diabetes</a>.</li>
</ul>
Several new product launches are on the radar for 2025. Bristol Myers Squibb &amp; Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BMY#NYSE">BMY</a>) stands out as a top pick, with the anticipated launch of <a target="_blank" href="https://www.benzinga.com/general/biotech/24/09/41064867/schizophrenia-treatment-revolution-fda-approves-bristol-myers-squibb-cobenfy-as-new-class-of-trea" rel="noreferrer noopener">Cobenfy for schizophrenia</a>.
JP Morgan analyst Chris Schott expects a strong adoption once broader insurance coverage, expected by the second half of 2025, is in place.
Gilead Sciences Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GILD#NASDAQ">GILD</a>) is also preparing for a mid-2025 launch of lenacapavir for pre-exposure prophylaxis, with promising uptake <a target="_blank" href="https://www.benzinga.com/24/12/42468692/gilead-unveils-new-yearly-hiv-injection-to-offer-hope-for-less-frequent-preventive-dosing" rel="noreferrer noopener">projected into 2026</a>.
Additionally, JP Morgan is monitoring Merck &amp; Co Inc&#8217;s (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MRK#NYSE">MRK</a>) Winrevair for pulmonary arterial hypertension, which has already <a target="_blank" href="https://www.benzinga.com/25/01/42768614/uk-approves-mercks-hypertension-drug-acquired-via-11-billion-acceleron-pharma-deal" rel="noreferrer noopener">exceeded early expectations</a>, and Gilead&#8217;s Livdelzi for primary biliary cholangitis, expected to see more significant growth in 2025 <a target="_blank" href="https://www.benzinga.com/general/biotech/24/11/42016935/gilead-unveils-long-term-data-from-seladelpar-in-patients-with-rare-liver-disease" rel="noreferrer noopener">as access improves</a>.
The analyst is watching for updates on how companies are approaching business development after a relatively quiet 2024. While major changes are not anticipated in the size or type of deals pursued by large-cap companies, JP Morgan expects M&amp;A activity to pick up in 2025.
Large deals over $25 billion remain unlikely, with mid-sized deals around $5-15 billion likely to focus on later-stage, lower-risk assets.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/general/biotech/25/01/42898400/sanofis-blood-cancer-drugs-new-subcutaneous-formulation-hits-primary-goal-in-late-stage-in-multiple-myeloma" target="_blank" rel="noreferrer noopener">Sanofi&#8217;s Blood Cancer Drug&#8217;s New Subcutaneous Formulation Hits Primary Goal In Late-Stage In Multiple Myeloma</a></li>
</ul>
Image via Shutterstock

Analyst Color

Biotech

Large Cap

Health Care

Analyst Ratings

AMGN

GILD

REGN

Obesity Treatments, M&A Activity To Take Center Stage During Upcoming JPM Healthcare Conference

Marvell Technology Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRVL#NASDAQ">MRVL</a>) shares are trading higher by some 7% to $118.23 over the trailing week. JPMorgan analyst Harlan Sur this week <a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/01/42859614/jpmorgan-sees-marvells-ai-revenue-surge-with-2-billion-run-rate-in-networking-by-2025">provided an optimistic outlook</a> for the company, highlighting the company's strong momentum in AI-driven growth.
Marvell also unveiled its <a href="https://www.benzinga.com/news/25/01/42820909/whats-going-on-with-marvell-technology-mrvl-stock">custom XPU architecture</a>, integrating co-packaged optics to enhance AI server scalability with superior data transmission reach and energy efficiency.
What To Know: Sur <a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/01/42859614/jpmorgan-sees-marvells-ai-revenue-surge-with-2-billion-run-rate-in-networking-by-2025">highlighted</a> that Marvell is set to surpass its $2.5 billion AI revenue target for CY25, fueled by robust demand for optical and copper networking products and AI ASIC programs with Amazon and Google.
Read Also: <a href="https://www.benzinga.com/25/01/42899028/la-wildfire-damages-estimated-above-52-billion-california-property-insurance-crisis">LA Wildfire Damages Could Top $52 Billion As California Faces Property Insurance Crisis</a>
The company is also expanding into scale-up networking with advanced solutions like active electrical cables, co-packaged optics and linear pluggable optics.
Sur noted Marvell's partnership with Amazon remained solid, with expectations of sustained multi-generational product wins. Despite competition from Amazon's 3nm AI compute ASIC program, Marvell anticipated no revenue disruptions through CY26, projecting continued growth.
Sur also described the company's $8 billion AI Custom ASIC revenue target for CY28 as conservative given the market's rapid expansion.
Read Also: <a href="https://www.benzinga.com/general/market-summary/25/01/42895251/mrvl-stock-has-gained-over-7-in-last-five-sessions-as-marvell-technologys-new-chip-boosts-ai-server-performance-heres-what-technical-analysis-says">MRVL Stock Has Gained Over 7% In Last Five Sessions As Marvell Technology&#8217;s New Chip Boosts AI Server Performance: Here&#8217;s What Technical Analysis Says</a>
<h1 class="wp-block-heading">Is MRVL A Good Stock To Buy?</h1>
An investor can make a few decisions when deciding whether a stock is a good buy. In addition to valuation metrics and price action which you can find on Benzinga's quote pages — such as <a href="https://www.benzinga.com/quote/MRVL">Marvell</a>&#8216;s page for example — there are factors like whether or not a company pays a dividend or buys a large portion of its stock each quarter.
These are known as capital allocation programs. Marvell Tech does pay a dividend, which yields 0.31% per year as of the closing price on Jan. 9, 2025. Feel free to search Benzinga's <a href="https://www.benzinga.com/calendars/dividends">dividend calendar</a> for the next company due to pay a dividend and determine what kind of yield you can earn for holding a share of the company.
For example, if you're looking to earn an annualized return of 18.34%, you'll need to buy a share of Orchid Island Cap by Jan. 31, 2025. Once done, you can expect to receive a nominal payout of $0.12 on Feb. 12, 2025.
Buyback programs are obviously different and highly variable. A company can approve a buyback program and purchase shares as it sees fit over the course of time in which the buyback was authorized. Looking through the latest news on <a href="https://www.benzinga.com/quote/MRVL">Marvell</a> will often yield whether or not the company has approved a buyback program recently. Buyback programs usually serve as a support for share prices, serving as a backstop for demand.
According to data from&nbsp;<a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, MRVL has a 52-week high of $126.12 and a 52-week low of $53.19.
Image courtesy of <a href="http://Pixabay">Pixabay</a>

Movers

Tech

MRVL

What's Going On With Marvell Technology (MRVL) Stock?

As Washington ramps up chip export restrictions to unfriendly countries, Nvidia Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) and Advanced Micro Devices Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>) are in the midst of a geopolitical power shift that could disrupt the semiconductor <a href="https://www.benzinga.com/topic/semiconductors">industry&#8217;s global landscape.</a>
In a report shared Monday, Bloomberg outlined the Biden administration&#8217;s imminent release of updated export <a href="https://www.benzinga.com/government/regulations/25/01/42897081/nvidia-and-ai-chip-stocks-brace-for-impact-as-biden-administration-considers-new-china-export-ban-report">rules targeting advanced semiconductors. </a>
The new measures, expected to drop Friday, intensify the U.S.&#8217;s strategic efforts to slow China's technological and military advancements by restricting access to high-performance computing chips.
<h3 class="wp-block-heading">New AI Export Framework: Allies And Adversaries</h3>
The regulations will reportedly create a three-tiered structure for semiconductor exports, emphasizing access tiers for key U.S. allies, neutral nations, and restricted countries. 
China is expected to fall under the most severe tier, joining nations such as Russia, Iran, and Venezuela.
This tier-based framework allows certain companies in restricted countries to bypass national limits by agreeing to U.S. security protocols and human rights standards. 
These entities, designated as validated end users, would have higher caps for chip purchases, a move aimed at encouraging safer AI development globally.
The measures expand the sweeping export restrictions initiated in October 2022, which already limited sales of advanced AI chips like Nvidia's Hopper GPUs. 
These earlier rules also prohibited U.S. firms and individuals from supporting Chinese chip development without explicit government approval. 
<h3 class="wp-block-heading">Nvidia And AMD Under Scrutiny</h3>
Nvidia's specialized A800 and H800 chips, developed to comply with prior regulations, could now fall under new restrictions, potentially denting AI giant&#8217;s upcoming revenues. 
According to data firm FactSet, China accounts for approximately 16% of Nvidia&#8217;s revenue, making it the company's second-largest market after the U.S. This marks a decline from 25% prior to the 2022 export restrictions.
In 2023, AMD generated roughly $3.4 billion in revenue from China, including Hong Kong, according to Statista. This represents 15% of the company&#8217;s total revenue of $22.7 billion.
<h3 class="wp-block-heading">Key ETFs Tied To Nvidia And AMD</h3>
Several ETFs heavily exposed to Nvidia and AMD could face ripple effects:
Top ETFs Holding Nvidia (Percentage of Holdings):
<ul>
<li>ProShares Ultra Semiconductors (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/USD#NYSE">USD</a>): 34.96%</li>
<li>Strive U.S. Semiconductor ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SHOC#NASDAQ">SHOC</a>): 21.10%</li>
<li>YieldMax Target 12 Semiconductor Option (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOXY#NASDAQ">SOXY</a>): 20.50%</li>
<li>VanEck Semiconductor ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMH#NASDAQ">SMH</a>): 20.21%</li>
<li>VanEck Fabless Semiconductor ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMHX#NASDAQ">SMHX</a>) – 20.11%</li>
</ul>
Top ETFs Holding AMD (Percentage of Holdings):
<ul>
<li>VanEck Video Gaming and Esports ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ESPO#NASDAQ">ESPO</a>): 8.01%</li>
<li>iShares Semiconductor ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOXX#NASDAQ">SOXX</a>): 7.12%</li>
<li>AOT Growth and Innovation ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AOTG#NASDAQ">AOTG</a>): 7.07%</li>
<li>Invesco PHLX Semiconductor ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOXQ#NASDAQ">SOXQ</a>): 7.04%</li>
<li>REX FANG &amp; Innovation Equity ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FEPI#NASDAQ">FEPI</a>): 6.95%</li>
</ul>
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/economics/macro-economic-events/25/01/42888800/goldman-sachs-flags-market-correction-risk-as-inflation-trump-policies-stir-uncertainty">Goldman Sachs Flags Market Correction Risk As Inflation, Trump Policies Stir Uncertainty</a></li>
</ul>
Image created using photos from Shutterstock.

Asia

Government

Regulations

Sector ETFs

Global

ETFs

AOTG

ESPO

FEPI

NVDA

EA Series Trust Strive U.S. Semiconductor ETF

SHOC

SMHX

SOXQ

iShares PHLX SOX Semiconductor Sector Index Fund

SOXX

SOXY

Biden's Final Chip Curbs Set To Shake AI Markets: 10 ETFs With High Stakes In Nvidia, AMD

<a target="_blank" href="https://www.benzinga.com/topic/airlines" rel="noreferrer noopener">Earlier this week</a> at CES 2025, Delta Air Lines, Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DAL#NYSE">DAL</a>) demonstrated Delta Concierge, an AI-powered digital tool that will add advanced capabilities to its Fly Delta app <a target="_blank" href="https://news.delta.com/delta-unveils-ai-powered-travel-journey-new-multi-modal-transportation-options" rel="noreferrer noopener">beginning in 2025</a>.
The airline also announced &#8216;multi-modal&#8217; transportation options offered through Delta partners Uber Technologies, Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UBER#NYSE">UBER</a>) and Joby Aviation, Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JOBY#NYSE">JOBY</a>).&nbsp;
The airline added Delta Concierge to the Fly Delta app for a seamless, personalized travel experience that leverages generative AI.&nbsp;
Also Read: <a target="_blank" href="https://www.benzinga.com/25/01/42872581/microns-7-billion-bet-on-ai-driven-memory-singapore-facility-set-to-boost-innovation-and-jobs" rel="noreferrer noopener">Micron&#8217;s $7 Billion Bet on AI-Driven Memory In Singapore Facility Set to Boost Innovation</a>
At CES in 2020, Delta previewed its &#8216;concierge&#8217; concept. Delta also previewed new partnerships with&nbsp;Uber and&nbsp;Alphabet Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) YouTube, including its expectations from its&nbsp;Joby partnership.&nbsp;
Delta is striving to build customer loyalty using data and AI. The AI assistant will work to create time-saving efficiencies, including notifying customers about passport expiration, visa requirements, weather updates, and wayfinding at unfamiliar airports.
In the future, Delta Concierge will enable customers to automatically connect to Delta Sync Wi-Fi and Delta Sync seatback, the airline&#8217;s personalized in-flight entertainment experience.
Delta also outlined a multimodal future of travel in which a single customer itinerary will be connected from start to finish through deep partner integrations. The Delta-Uber partnership will allow customers to earn miles for eligible rides and deliveries.
Delta Concierge will also connect with Joby&#8217;s&nbsp;electric air taxi&nbsp;service. Delta and Joby announced their alliance in 2022 and expect to begin operating in Delta&#8217;s New York and Los Angeles hubs.
B Of A Securities&#8217; Andrew G. Didora <a target="_blank" href="https://www.benzinga.com/25/01/42824930/bofa-expects-deltato-maintain-10-eps-growth-in-2025-sees-strong-q4-result" rel="noreferrer noopener">raised estimates for</a> Delta ahead of its fourth-quarter print. Didora raised the quarterly revenue growth estimate to 4.3% (prior 3.6%), versus the 2%-4% outlook. He expects EPS of $1.78 versus the guidance of $1.60-$1.85.
Morgan Stanley&#8217;s Ravi Shankar maintained&nbsp;<a target="_blank" href="https://www.benzinga.com/general/travel/24/12/42450095/us-airlines-set-to-fly-high-in-2025-analyst-says-perfect-storm-of-tailwinds-will-propel-industry-gains" rel="noreferrer noopener">a bullish outlook</a> on the airline industry. The analyst flagged how airlines like Delta reaped the benefits of &#8220;the premiumization trend,&#8221; backed by loyalty programs, credit cards, and brand partnerships. Goldman Sachs&#8217; Catherine O&#8217;Brien <a target="_blank" href="https://www.benzinga.com/24/11/42119662/goldman-sachs-analyst-sees-delta-eps-soaring-to-950-by-fy26-details" rel="noreferrer noopener">also voiced similar</a> sentiments.
Delta chief Ed Bastian&nbsp;had signaled <a target="_blank" href="https://www.benzinga.com/news/global/24/11/42106369/delta-chief-says-trump-could-be-a-breath-of-fresh-air-for-aviation-industry" rel="noreferrer noopener">positive regulatory changes</a> for the industry under Donald Trump&#8217;s presidency.
Delta stock surged over 45% in the last 12 months. Investors can gain exposure to the stock through U.S. Global Jets ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JETS#NYSE">JETS</a>) and iShares U.S. Financial ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IYF#NYSE">IYF</a>).
Price Action: DAL stock closed at $61.18 on Wednesday.
Also Read:
<ul>
<li><a href="https://www.benzinga.com/25/01/42871786/acuity-brands-earnings-beats-profit-estimates-smart-spaces-revenue-soars-145-expands-into-cloud-tech-with-12-billion-deal" target="_blank" rel="noreferrer noopener">Acuity Brands Q1 Earnings: Revenue Miss, Smart Spaces Revenue Soars 14.5%, Expands Into Cloud Tech With $1.2 Billion Deal</a></li>
</ul>
Photo by VanderWolf via Shutterstock

GOOG

GOOGL

iShares Dow Jones US Financial Sector Index Fund

JETS

JOBY

UBER

Delta Expands Premium Travel Experience with Uber, YouTube, and Joby Partnerships

President Jimmy Carter's solemn <a href="https://www.benzinga.com/movers-shakers/24/12/42716329/jimmy-carter-the-39th-us-president-who-championed-human-rights-and-peace-in-the-middle-east-had-died">state funeral</a> in Washington, D.C.&#8217;s National Cathedral Thursday brought together five living U.S. presidents, including President-elect Donald Trump, who was seated next to Barack Obama, with whom he seemed to be having a lively conversation. &nbsp;
Carter was <a href="https://www.benzinga.com/topic/jimmy-carter">president from 1977 to 1981.</a>
The first eulogy was given by one of Carter's grandsons, Joshua Carter, who said his grandfather spent his life helping people and seeking peace and justice around the world. He was followed by eulogies written by former President Gerald Ford and Walter Mondale, Carter&#8217;s vice president, before their deaths and read by the sons.
<h1 class="wp-block-heading">&#8220;The First Millennialist&#8221;</h1>
Jason Carter called his grandfather the first millennialist who wanted to legalize cannabis, encouraged craft beer production, protected the environment, supported women's rights and "tried to bring peace to the Holyland."
He drew laughs when he told an endearing story about how his grandfather, a nuclear engineer, first began using a cell phone and called him: &#8220;I answered and said &#8216;Hey paw paw.&#8217; He said &#8216;Who&#8217;s this.&#8217; I said this is Jason, you called me.&#8221; 
Carter replied, &#8220;I didn&#8217;t call you, I&#8217;m taking a picture.&#8221;
<h2 class="wp-block-heading">President Joe Biden</h2>
In his eulogy, President Joe Biden summed up Carter's character in three words "Character, character, character." He called Carter a white Southerner who championed civil rights and established a model post-presidency.
"He showed us how character and faith start with ourselves and then flows to others. At our best, we share the better parts of ourselves — joy, solidarity, love, commitment — not for reward, but in reverence of the incredible gift of life we've all been granted, to make every minute of our time here on Earth count," Biden said. 
&#8220;We have an obligation to give hate no safe harbor and we have to stand up to what my dad used to say was the greatest sin of all — the abuse of power." At this point the cameras turned to the section of the audience where Trump was seated.
As the presidents made their way to the exit of the Cathedral, Trump, Obama and Bush went one way and Clinton another, <a href="https://www.nytimes.com/live/2025/us/jimmy-carter-funeral">noted</a> the NY Times. Doug Emhoff, Vice President Kamala Harris's husband shook Trump&#8217;s hand, which Bush did not, <a href="https://www.newsbreak.com/raw-story-2096750/3752745200176-watch-george-w-bush-declines-to-shake-donald-trump-s-hand-at-jimmy-carter-s-funeral">noted</a> CBS anchor Norah O&#8217;Donnell.
<h1 class="wp-block-heading">Final Resting Place</h1>
Following the service, Carter was taken to the Joint Base Andrews outside of Washington, D.C., to be flown on one of Air Force One jets to Georgia where there will be a final private service Thursday afternoon at Carter&#8217;s local church. Carter will be buried next to his wife, <a href="https://www.benzinga.com/top-stories/23/11/35865944/former-first-lady-and-mental-health-champion-rosalynn-carter-dies-at-96">Rosalynn Carter</a>, outside the home they built in 1961 and where they lived most of their lives.
&#8220;Yes, they spent four years in the governor's mansion and four years at the White House but the other 92 years they spent at home in Plains, Georgia, which first of all looks like they built themselves," said grandson Jason Carter.
"Second of all, my grandfather was likely to show up at the door in some &#8217;70s short shorts and crocs. Demonstrating their depression, era roots, they had a little rack next to the sink where they would hang Ziploc bags to dry."
Photo: Jimmy Carter in 1977; Photo by Bernard Gotfyd via Library of Congress

Cannabis

Jimmy Carter's Funeral: 5 Living Presidents Attend; Family, Colleagues Share Warm, Humorous Stories

Chevron Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVX#NYSE">CVX</a>) disclosed the commencement of oil production from the Whale semi-submersible platform in the<a target="_blank" href="https://www.benzinga.com/pressreleases/25/01/b42899245/chevron-bolsters-u-s-gulf-of-mexico-production-with-whale-facility-startup" rel="noreferrer noopener"> deepwater U.S. Gulf of Mexico</a>.
The company&#8217;s subsidiary, Chevron U.S.A. Inc., owns 40% working interest in Whale, with Shell Offshore Inc. owning 60% interest as operator.
Whale, located 200 miles southwest of Houston in Alaminos Canyon Block 773, is in over 8,600 feet of water.
The company estimates Whale&#8217;s peak production at 100,000 gross boe/d, with up to 15 wells in its first phase.
The project features energy-efficient gas turbines and compression systems, utilizing a simplified design for lower emissions, reduced costs, and higher returns.
Chevron&#8217;s latest milestone follows a year of key achievements, including first production from its high-pressure Anchor project and the launch of water injection operations to enhance output at its Jack/St. Malo and Tahiti facilities in the Gulf.
Bruce Niemeyer, president of Chevron Americas Exploration &amp; Production, stated Whale&#8217;s production brings Chevron nearer to its target of 300,000 net barrels of oil equivalent per day in the U.S. Gulf of Mexico by 2026.
Last month, Chevron and Woodside swapped energy assets, with Chevron gaining Julimar-Brunello stakes and <a target="_blank" href="https://www.benzinga.com/news/contracts/24/12/42584936/chevron-secures-larger-north-west-shelf-stake-in-asset-swap-400m-payment-to-woodside" rel="noreferrer noopener">Woodside focusing on LNG assets</a>.
Investors can gain exposure to the stock via EA Series Trust Strive U.S. Energy ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DRLL#NYSE">DRLL</a>) and SPDR Select Sector Fund &#8211; Energy Select Sector (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLE#NYSE">XLE</a>).
Price Action: CVX shares closed higher by 0.47% at $150.30 on Wednesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/01/42883117/in-an-unpredictable-market-here-are-some-potential-winners-and-losers-for-the-first-quarter" target="_blank" rel="noreferrer noopener">In an Unpredictable Market Here Are Some Potential Winners and Losers for the First Quarter</a></li>
</ul>
Image via Shutterstock.

Equities

DRLL

Chevron Kicks Off Whale Oil Production: Details

Western Midstream's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WES#NYSE">WES</a>) short percent of float has fallen 16.26% since its last report. The company recently reported that it has 5.18 million shares sold short, which is 2.73% of all regular shares that are available for trading. Based on its trading volume, it would take traders 4.6 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Western Midstream Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1736448321_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Western Midstream has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Western Midstream's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Western Midstream's peer group average for short interest as a percentage of float is 4.15%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

Trading Ideas

Peering Into Western Midstream's Recent Short Interest

Ally Financial's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALLY#NYSE">ALLY</a>) short percent of float has fallen 8.82% since its last report. The company recently reported that it has 7.53 million shares sold short, which is 2.48% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.31 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Ally Financial Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1736448316_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Ally Financial has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Ally Financial's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Ally Financial's peer group average for short interest as a percentage of float is 6.81%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

ALLY

Looking Into Ally Financial's Recent Short Interest

Public Service Enterprise's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PEG#NYSE">PEG</a>) short percent of float has fallen 9.45% since its last report. The company recently reported that it has 4.41 million shares sold short, which is 1.15% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.87 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Public Service Enterprise Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1736448311_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Public Service Enterprise has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Public Service Enterprise's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Public Service Enterprise's peer group average for short interest as a percentage of float is 2.98%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Looking Into Public Service Enterprise's Recent Short Interest

Eighteen years ago, on Jan. 9, 2007, Apple Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) co-founder Steve Jobs walked onto the stage at the Macworld Conference and <a href="https://www.benzinga.com/news/23/01/30336631/the-iphone-was-unveiled-16-years-ago-heres-how-much-1-000-invested-in-apple-stock-after-the-debut-is">changed the world</a>.
What Happened: Steve Jobs began his presentation by building suspense. He teased the audience by saying, &#8220;Today, we are introducing three revolutionary products.&#8221;
He described them as &#8220;a widescreen iPod with touch controls,&#8221; &#8220;a revolutionary mobile phone,&#8221; and a &#8220;breakthrough internet communications device.&#8221;
See Also: <a href="https://www.benzinga.com/markets/equities/25/01/42837406/amid-nvidias-ces-2025-buzz-investors-overlooked-apple-supplier-foxconns-strong-q4-says-jim-cramer">Amid Nvidia&#8217;s CES 2025 Buzz, Investors Overlooked Apple Supplier Foxconn&#8217;s Strong Q4, Says Jim Cramer</a>
Then, in dramatic fashion, he revealed that these weren't three separate devices but one — the iPhone. &#8220;Today, Apple is going to reinvent the phone,&#8221; he said.
The original iPhone featured a 3.5-inch display, a 2-megapixel camera, and a multi-touch interface—which was a novel feature at the time. Jobs demonstrated how the iPhone eliminated the need for physical buttons and a stylus, showing off its intuitive design.
Subscribe to the <a href="https://bztechtrends.beehiiv.com/subscribe">Benzinga Tech Trends newsletter</a> to get all the latest tech developments delivered to your inbox.
How Much Would a $1,000 Investment in Apple Be Worth Today?
If you had invested $1,000 in Apple stock on Jan. 10, 2007—the day after the iPhone was first announced—your investment would have grown astronomically.
On Jan. 10, 2007, Apple stock was priced at $3.38, adjusted for splits, bonus issues, and other corporate actions. A $1,000 investment would have bought approximately 295.86 shares.
With Apple's current stock price at $242.70, the original investment is now worth: $71,804.
This reflects a total return of 7,080% over 18 years.
The iPhone Effect
The iPhone made its official debut in the U.S. on June 29, 2007. It has not only transformed Apple's fortunes but also changed how we live.
Today, Apple is the most valuable company in the world, with a market cap of $3.668 trillion. iPhones are a key contributor to Apple&#8217;s financial success, accounting for roughly half of the company&#8217;s overall revenue.
In the <a href="https://www.benzinga.com/news/earnings/24/10/41666494/apple-q4-earnings-revenue-beat-eps-beat-installed-base-hits-new-highs-iphone-sales-rise-as-apple-in">fourth quarter</a>, Apple surpassed expectations with $94.9 billion in revenue. iPhone sales reached $46.22 billion, an increase from $43.8 billion in the same period last year.
Check out more of Benzinga&#8217;s Consumer Tech coverage by <a href="https://www.benzinga.com/topic/consumer-tech">following this link</a>.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/12/42513402/apples-2025-bull-case-can-it-deliver-without-riding-the-ai-wave?itm_source=parsely-api">Apple&#8217;s 2025 Bull Case: Can It Deliver Without Riding The AI Wave?</a></li>
</ul>
Disclaimer: This content was partially produced with the help of <a href="https://www.benzinga.com/author/benzinga-neuro">Benzinga Neuro</a> and was reviewed and published by Benzinga editors.
Photo courtesy: Apple

AAPL

Apple Announced iPhone 18 Years Ago Today, Changing The Smartphone Industry Forever. Here's How Much You'd Have Now If You Invested $1,000 Back Then

Quantum computing stocks like Rigetti Computing, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGTI#NASDAQ">RGTI</a>) and IonQ, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IONQ#NYSE">IONQ</a>) were clobbered Wednesday following comments from NVIDIA Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) CEO Jensen Huang suggesting the technology is decades away<a href="https://www.benzinga.com/markets/equities/25/01/42867168/nvidias-jensen-huang-said-something-that-has-all-quantum-computing-stocks-tumbling-qubt-and-rgti-down-13-ionq-down-11"> from practical use.&nbsp;</a>
What To Know: Huang commented on the future of quantum computing at an investor event on Tuesday sending quantum stocks plunging in after-hours trading.&nbsp;
&#8220;If you kind of said 15 years for very useful quantum computers, that would probably be on the early side. If you said 30, it&#8217;s probably on the late side,&#8221; Huang said. &#8220;If you picked 20, I think a whole bunch of us would believe it.&#8221;
Read Next: <a href="https://www.benzinga.com/25/01/42899028/la-wildfire-damages-estimated-above-52-billion-california-property-insurance-crisis">LA Wildfire Damages Could Top $52 Billion As California Faces Property Insurance Crisis</a>
Following Huang's comments, quantum stocks<a href="https://www.benzinga.com/markets/equities/25/01/42890014/jim-cramer-warns-on-quantum-stories-as-stocks-plunge-we-need-you-out-before-the-froth-goes-away"> plummeted </a>further on Wednesday with Rigetti Computing stock closing down 43.8%, D-Wave Quantum Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/QBTS#NYSE">QBTS</a>) down 36% and IonQ shares ending the session down by 39%.&nbsp;
Expert Ideas: Some experts have suggested that Huang may have had ulterior motives behind his comments on quantum computing's long-term outlook.&nbsp;
&#8220;Any dollar chasing quantum computing stocks is not chasing AI stocks,&#8221; said Thomas Hayes, chairman of Great Hill Capital, per Reuters.&nbsp;
&#8220;Jensen threw a wet blanket on the quantum story and did everything he could to sell the AI story. It&#8217;s that simple,&#8221; Hayes added.&nbsp;
Another analyst echoed similar sentiments on <a href="https://www.benzinga.com/tech/25/01/42879725/nvidia-ceo-sends-quantum-stocks-lower-poll-finds-over-50-pick-rigetti-or-skip-for-2025">quantum computing</a> as a potential threat to Nvidia's dominance:&nbsp;Quantum computing &#8220;will be disruptive to parts of the classical compute business, of which Nvidia is a chief beneficiary,&#8221; Craig-Hallum analyst Richard Shannon said, per Reuters.&nbsp;
CEO Fires Back: D-Wave Quantum CEO Alan Baratz<a href="https://www.benzinga.com/25/01/42892470/jensen-huang-is-dead-wrong-about-quantum-computing-d-wave-ceo-fires-back-at-nvidia-boss-happy-to-meet-with-jensen-any-time-any-place-to-help-fill-in-these-gaps"> also criticized </a>Huang for his comments on the timeline for achieving practical quantum computing, saying the Nvidia CEO is "dead wrong." Baratz said D-Wave's quantum computers are already in commercial use by major companies including Mastercard.&nbsp;
&#8220;Not 30 years from now, not 20 years from now, not 15 years from now,&#8221; he said, adding, &#8220;But right now today.&#8221;
Poised To Recover: Quantum stocks look poised to open higher Friday (after Thursday&#8217;s national day of mourning for President Jimmy Carter and the U.S. markets are closed) after recovering slightly in Wednesday's after-hours session. D-Wave Quantum rose 6.89%, Rigetti Computing gained 2.89% and IonQ gained 5.92% after Wednesday's closing bell. 
Read Next:
<ul>
<li><a href="https://www.benzinga.com/general/biotech/25/01/42854890/us-records-first-human-bird-flu-death-high-levels-of-respiratory-illnesses-vaccine-stocks-rally">US Records First Human Bird Flu Death, High Levels Of Respiratory Illnesses: Vaccine Stocks Rally&nbsp;</a></li>
</ul>
Photo: Shutterstock

IONQ

QBTS

RGTI

Quantum Stocks Regetti Computing, IonQ, D-Wave Poised To Open Higher After Nvidia CEO Comments Drove Huge Losses

The exploration will expand upon Aimco's ongoing efforts such as reducing exposure to development activity and monetizing certain assets, and include, but not be limited to, exploration of potential sales of the major components of the business, an acceleration of individual asset sales, or a sale or merger of the Company as a whole.

Aimco Board Decides To Explore Additional Alternatives To Further Maximize Shareholder Value

The <a href="https://europeancapitalinsights.substack.com/p/us-dollar-drops-on-report-of-trump?r=3nmatg" target="_blank" rel="noreferrer noopener nofollow">US dollar has had a volatile start </a>to the week, sparked by a report that President-elect Donald Trump's tariff plan may shift. 
The US dollar index fell 0.8% to 108.1 on Monday, then pared losses after Trump denied a Washington Post <a href="https://www.washingtonpost.com/business/2025/01/06/trump-tariff-economy-trade/" target="_blank" rel="noreferrer noopener nofollow">report</a>. The newspaper <a href="https://www.washingtonpost.com/business/2025/01/06/trump-tariff-economy-trade/" target="_blank" rel="noreferrer noopener">reported </a>that Trump may scale back his plans for widespread tariffs when he returns to the White House on January 20.
<img loading="lazy" decoding="async" width="624" height="432" src="https://lh7-rt.googleusercontent.com/docsz/AD_4nXd_RGvHuitxxEnhHBiJrmZ-kncDNXMvANjtEtMWQDLP3OfXPKdyryWrQ7eDEc-MlPxPSvrEiO9wxwvjUaA-3i_ErL0ctVqYGChWPYYM5ge_Y3G2Ec3YEVRcEdH5BEeCib4Oxc0SkQ?key=8BnLmCWTfgOqaBXXQhelQTxZ" />
US Dollar Index, Monday, January 6 Session, Source: <a href="https://tradingeconomics.com/united-states/currency">Trading Economics</a>
Citing people familiar with the matter, the newspaper reported that Trump's aides are exploring tariff plans that would be applied to every country but only cover critical imports. This would mark a significant shift from his presidential campaign plans.
Trump, though, denied the newspaper's reporting on <a href="https://truthsocial.com/@realDonaldTrump#:~:text=The%20story%20in%20the%20Washington%20Post%2C%20quoting%20so%2Dcalled%20anonymous%20sources%2C%20which%20don%27t%20exist%2C%20incorrectly%20states%20that%20my%20tariff%20policy%20will%20be%20pared%20back.%20That%20is%20wrong.%20The%20Washington%20Post%20knows%20it%27s%20wrong.%20It%27s%20just%20another%20example%20of%20Fake%20News" target="_blank" rel="noreferrer noopener">Truth Social</a>. 
"The story in the Washington Post, quoting so-called anonymous sources, which don&#8217;t exist, incorrectly states that my tariff policy will be pared back," he wrote on his social media platform. "The Washington Post knows it&#8217;s wrong. It&#8217;s just another example of Fake News."&nbsp;&nbsp;
<h2 class="wp-block-heading">US Dollar Reacts to Trump Tariff Plans</h2>
The reporting fueled uncertainty about one of Trump's key policy proposals. In response, the dollar declined sharply against most major currencies.
The Bloomberg Dollar Spot Index (BBDXY), which measures the value of the US dollar relative to other major global currencies, ended the session 0.6% lower on Monday. After the publication of the Washington Post article, the index lost 1%, marking the largest <a href="https://www.bloomberg.com/news/articles/2025-01-06/dollar-falls-most-in-two-months-on-report-trump-to-limit-tariffs" target="_blank" rel="noreferrer noopener">intraday drop since 2023</a>. 
Meanwhile, <a href="https://www.bloomberg.com/news/articles/2025-01-06/dollar-falls-most-in-two-months-on-report-trump-to-limit-tariffs" target="_blank" rel="noreferrer noopener">the euro gained 1.3%</a> the same day against the US dollar (EUR/USD), the common currency's largest intraday gain in 14 months. The British pound (GBP/USD rose as much as 1%.
<figure class="wp-block-image"><img loading="lazy" decoding="async" width="1200" height="832" src="https://contributor-assets.benzinga.com/wp-content/uploads/2025/01/09171618/image-2.png" alt="" class="wp-image-4571" srcset="https://contributor-assets.benzinga.com/wp-content/uploads/2025/01/09171618/image-2.png 1200w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/01/09171618/image-2-300x208.png 300w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/01/09171618/image-2-1024x710.png 1024w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/01/09171618/image-2-768x532.png 768w" sizes="(max-width: 1200px) 100vw, 1200px" /></figure>
US Dollar Index vs. EURUSD vs. GBPUSD, Monday, January 6 Session, Source: <a href="https://tradingeconomics.com/united-states/currency">Trading Economics</a>
The initial loss in the dollar was "an outsized reaction to an unverified report, but it does show the direction of travel,"Kathleen Brooks, the director of research at XTB, told Bloomberg. "We've had a large buildup of dollar longs and they are at risk of a turnaround."
<h2 class="wp-block-heading">Trump Tariff Plans Go Back to 2024</h2>
During his 2024 presidential campaign, Trump vowed to<a href="https://www.piie.com/blogs/realtime-economics/2024/no-trade-tax-free-trumps-promised-tariffs-will-hit-large-flows" target="_blank" rel="noreferrer noopener"> impose 10-20% tariffs</a> on all imported goods, with tariffs as high as 60% on Chinese products. After his election win in November, he threatened to impose additional tariffs of 10% on Chinese goods and 25% on all imports from Mexico and Canada.
With Trump's aim to raise US revenues, he will likely go ahead with some of his tariff plans. He may threaten to use them until he gains the upper hand in trade negotiations.
"Members of Congress are getting to work on one powerful Bill that will bring our Country back," Trump said. "It will all be made up with tariffs, and much more, from countries that have taken advantage of the US."&nbsp;&nbsp;
A Bloomberg Economics <a href="https://www.bloomberg.com/news/articles/2025-01-06/trump-keeps-keeps-his-negotiating-powder-dry-with-tariff-turmoil" target="_blank" rel="noreferrer noopener nofollow">study</a> suggests that higher tariffs could lead to increased inflation and a decline in US GDP. By 2028, US GDP could shrink by 0.8% if only China retaliates. If other countries impose tariffs, US economic growth could slow to 1.3%. 
Trump&#8217;s tariff could hurt global economic growth and drive up consumer prices, particularly if other governments retaliate.
<figure class="wp-block-image"><img loading="lazy" decoding="async" width="768" height="791" src="https://contributor-assets.benzinga.com/wp-content/uploads/2025/01/09171617/image.png" alt="" class="wp-image-4569" srcset="https://contributor-assets.benzinga.com/wp-content/uploads/2025/01/09171617/image.png 768w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/01/09171617/image-291x300.png 291w" sizes="(max-width: 768px) 100vw, 768px" /></figure>
Trump's Tariff Increases to Impact Poorest Americans, Source: <a href="https://itep.org/trump-tariffs-tax-increase-impact/">ITEP</a>
<h2 class="wp-block-heading">Trump Tariff Plans Target Critical Sectors</h2>
The dollar had strengthened amid expectations that Trump will impose tariffs on the US&#8217;s major trading partners. This <a href="https://europeancapitalinsights.substack.com/p/dovish-ecb-drives-7-eurusd-drop-in?r=3nmatg" target="_blank" rel="noreferrer noopener">put pressure</a> on other currencies. 
However, the dollar could weaken from a tariff program focused solely on sectors deemed critical to national or economic security. This would have a lesser effect on the global economy and US inflation than a broader tariff approach.
According to The Washington Post, it remains unclear which imports or industries might be targeted by tariffs. However, preliminary discussions have centered on sectors considered vital to national or economic security.&nbsp;
These could include the defense industrial supply chain, critical medical supplies, and energy production.
<figure class="wp-block-image"><img loading="lazy" decoding="async" width="1200" height="768" src="https://contributor-assets.benzinga.com/wp-content/uploads/2025/01/09171618/image-1.png" alt="" class="wp-image-4570" srcset="https://contributor-assets.benzinga.com/wp-content/uploads/2025/01/09171618/image-1.png 1200w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/01/09171618/image-1-300x192.png 300w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/01/09171618/image-1-1024x655.png 1024w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/01/09171618/image-1-768x492.png 768w" sizes="(max-width: 1200px) 100vw, 1200px" /></figure>
Critical Sector Tariffs Forecast to Weigh on Dollar, Source: <a href="https://www.corpay.com/resources/market-analysis/market-brief-potential-dilution-in-trump-tariff-plans-pummels-dollar">Corpay</a>
The uncertainty of Trump tariffs and whether his administration will target Europe's auto sector led to a near 3% surge in the Euro Stoxx Automobiles &amp; Parts <a href="https://stoxx.com/index/sxagt/">index</a>. Europe&#8217;s <a href="https://stoxx.com/index/sxxp/">STOXX 600</a> closed 0.9% higher alongside France&#8217;s <a href="https://www.marketwatch.com/investing/index/px1?countrycode=fr">CAC 40</a>, up 2.2%, and Germany&#8217;s <a href="https://stoxx.com/index/dax/">DAX</a> up 1.5%.
Some of Europe's major luxury brands also gained from the optimism of more selective tariffs. LVMH (OTC:<a class="ticker" href="https://www.benzinga.com/stock/LVMUY#OTC">LVMUY</a>), Hermes (OTC:<a class="ticker" href="https://www.benzinga.com/stock/HESAY#OTC">HESAY</a>), and Kering (OTC:<a class="ticker" href="https://www.benzinga.com/stock/PPRUY#OTC">PPRUY</a>) all rose over 2%.
European markets overall closed higher on January 6, driven by investor optimism that US tariffs might be less severe than initially feared. However, speculation surrounding the incoming administration&#8217;s agenda will likely be accompanied by heightened market volatility.
Disclaimer:
Any opinions expressed in this article are not to be considered investment advice and are solely those of the authors. European Capital Insights is not responsible for any financial decisions made based on the contents of this article. Readers may use this article for information and educational purposes only.
This article is from an unpaid external contributor. It does not represent Benzinga&#8217;s reporting and has not been edited for content&nbsp;or&nbsp;accuracy.

Eurozone

HESAY

LVMUY

PPRUY

US Dollar Drops on Report of Trump Tariff Plan Shift

The intersection of celebrity and policy debates took center stage this week when bestselling author Stephen King criticized billionaire <a href="https://www.benzinga.com/startups/25/01/42805245/elon-musk-nearly-sold-struggling-tesla-to-google-for-6-billion-but-when-he-no-longer-needed-a-savior-the-deal-was-called-off">Elon Musk</a> over his stance on H-1B visas. In a post on Bluesky, King aimed Musk's apparent preference for highly skilled immigrants, writing: "Musk thinks it's OK for smart immigrants to hang around. The rest of you guys who wash dishes, drive trucks, cook meals … just get lost."
<figure class="wp-block-embed"> 
<div class="wp-block-embed__wrapper">
<a href="https://bsky.app/profile/stephenking.bsky.social/post/3lepj3fwvik2s" title="https://bsky.app/profile/stephenking.bsky.social/post/3lepj3fwvik2s">https://bsky.app/profile/stephenking.bsky.social/post/3lepj3fwvik2s</a>
</div>
</figure>
Don't Miss:
<ul>
<li>The global games market is projected to generate $272B by the end of the year —<a href="https://www.benzinga.com/money/gameflip"> for $0.55/share, this VC-backed startup with a 7M+ userbase gives investors easy access to this asset market.</a></li>
<li>Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target – <a href="https://www.benzinga.com/money/mode-mobile-2">Many are rushing to grab 4,000 of its pre-IPO shares for just $0.26/share!</a></li>
</ul>
King's comment reflects broader concerns about how immigration policies prioritize certain workers while leaving others behind, particularly those surrounding the H-1B visa program. The program, established under the Immigration Act of 1990, allows U.S. companies to hire highly skilled foreign workers for specialized technology, engineering and science roles. While proponents argue it fills critical labor gaps, critics claim it displaces American workers and drives down wages in key industries.
Musk, a vocal advocate for the program and a beneficiary of it during his early years in the United States, has defended H-1B visas with fervor. In late December, Musk posted on X: "The reason I'm in America along with so many critical people who built SpaceX, Tesla and hundreds of other companies that made America strong is because of H1B. Take a big step back and F&#x2A;&#x2A; YOURSELF in the face. I will go to war on this issue the likes of which you cannot possibly comprehend."
See Also: <a href="https://www.benzinga.com/money/qnetic-2">This 12,000 RPM Spinning Battery With Over $100 Million In LOIs Could Be The Missing Link For Green Energy — Here&#8217;s Why Early Investors Are Flocking To Invest Before Funding Closes</a>
According to Newsweek, Musk's support for the visa program aligns with his business interests, as Tesla hired over 700 H-1B workers in 2023 alone. Yet his stance has sparked a backlash among Trump-aligned conservatives, who view the program as inconsistent with "America First" policies.
Conservative activist Laura Loomer, for example, criticized Musk and Trump for their support of H-1B visas, accusing them of prioritizing Silicon Valley interests over American workers.&nbsp;
In December, Trump maintained a favorable view of the program, telling the New York Post: "I've always liked the visas. I have always been in favor of the visas. That's why we have them. I have many H-1B visas on my properties. I've been a believer in H-1B. I have used it many times. It's a great program."
King's criticism adds a cultural dimension to what has largely been an economic and political debate. Known for his outspoken views on social media, King often uses his platform to comment on political and social issues, from gun control to presidential elections. This isn't the first time the author has clashed with Musk online – King has previously mocked and disagreed with Musk on X, fueling an <a href="https://www.benzinga.com/news/24/11/41709658/stephen-king-slams-elon-musk-claims-most-of-his-posts-spread-pro-trump-disinformation-and-outright-l">ongoing public feud between the two</a>.
Trending: Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing —<a href="https://www.benzinga.com/money/boxabl"> you can become an investor for $0.80 per share today.</a>
The H-1B visa program remains a polarizing topic. Critics, including Vermont Sen. Bernie Sanders, argue it <a href="https://www.benzinga.com/personal-finance/24/12/42494409/bernie-sanders-proposes-taxing-income-over-1-billion-at-100-and-urges-its-time-to-make-greedy-billionaires-pay-their-fair-share">benefits billionaires</a> and corporations at the expense of American workers.&nbsp;
Others, like Jeanne Batalova of the Migration Policy Institute, see the program as essential for addressing labor shortages in specialized industries. Speaking to Yahoo Finance, Batalova noted, "This program should not and was not intended to substitute American talent. It was designed to supplement it and, by and large, it has been working."&nbsp;
Musk is both a symbol of the program's potential success and a lightning rod for criticism. Meanwhile, King's sharp critique highlights the social implications of immigration policies that prioritize certain workers over others.
As <a href="https://www.benzinga.com/personal-finance/24/12/42488326/grant-cardone-offer-citizenship-to-1-million-immigrants-who-deposit-5-million-each-5-trillion-in-new-investment-dollars-for-america">debates over immigration</a> reform continue, the tension between economic pragmatism and cultural values remains unresolved. King's comments may not sway policymakers, but they have amplified a conversation that extends beyond the tech industry and into the heart of America's identity as a nation of immigrants.
Read Next:
<ul>
<li>Inspired by Uber and Airbnb &#8211; Deloitte's fastest-growing software company is transforming 7 billion smartphones into income-generating assets &#8211; <a href="https://www.benzinga.com/money/mode-mobile-2">with $1,000 you can invest at just $0.26/share!</a></li>
<li><a href="https://www.benzinga.com/money/elon-musk-told-the-u-n-if-they-could-show-a-plan-for-ending-world-hunger-hed-donate-6-billion-i-will-sell-tesla-stock-right-now-and-do-it">Elon Musk Told The U.N. If They Could Show A Plan For Ending World Hunger He'd Donate $6 Billion – ‘I Will Sell Tesla Stock Right Now And Do It'</a></li>
</ul>

Stephen King Slams Elon Musk's H-1B Visa Stance: 'Musk Thinks Smart Immigrants Can Stay – The Rest of You Washing Dishes … Get Lost'

Robinhood Markets Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOOD#NASDAQ">HOOD</a>) slipped 0.6% in Wednesday&#8217;s after-hours session following a volatile trading day. The decline came as new employment data pointed to a <a href="https://www.benzinga.com/economics/macro-economic-events/25/01/42873182/us-private-businesses-add-122000-jobs-in-december-the-labor-market-downshifted-to-a-more-modest-pace-of-growth">cooling U.S. labor market</a>, sparking concerns about a potential drop in retail trading activity and waning investor engagement on the platform.
What To Know: The ADP National Employment Report showed private employers added just 122,000 jobs in December, missing expectations and highlighting a slowdown in key sectors like manufacturing and trade.
Robinhood's business model relies heavily on retail trading volumes, which are sensitive to economic conditions affecting individual investors. 
A weakening labor market, coupled with slowing wage growth, reduces disposable income and dampens investor confidence — key drivers of trading activity on the platform. This can lead to lower revenue from payment for order flow, which represents a substantial portion of Robinhood's income.
Read Also: <a href="https://www.benzinga.com/economics/macro-economic-events/25/01/42881085/is-labor-market-cooling-or-raising-fed-concerns-what-to-watch-in-fridays-jobs-report">Is Labor Market Cooling Or Raising Fed Concerns? What To Watch In Friday&#8217;s Jobs Report</a>
Additionally, decelerating wage gains could limit the influx of new retail investors, particularly younger users who form a significant portion of Robinhood's customer base. With fewer opportunities for speculative trading and reduced enthusiasm for high-risk assets, the platform may face declining engagement.
The broader economic uncertainty, including <a href="https://www.benzinga.com/news/25/01/42884213/dollar-hits-14-month-high-30-year-yields-near-critical-threshold-as-trump-reportedly-mulls-economic">elevated Treasury yields</a> and Federal Reserve tightening, compounds these risks, potentially eroding Robinhood's revenue streams tied to options and cryptocurrency trading, two of its most lucrative segments.
<h2 class="wp-block-heading">How To Buy Robinhood Stock</h2>
Besides going to a brokerage platform to purchase a share — or fractional share — of stock, you can also gain access to shares either by buying an exchange-traded fund (ETF) that holds the stock itself or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instrument.
For example, in Robinhood Markets&#8217; case, it is in the Financials sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.
According to data from&nbsp;<a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, Robinhood has a 52-week high of $43.83 and a 52-week low of $10.38.
Now Read:
<ul>
<li><a href="https://www.benzinga.com/25/01/42899953/five-dead-in-los-angeles-wildfires-utilities-face-scrutiny">5 Dead, Nearly 180,000 Evacuated In Los Angeles Wildfires: California Utilities Face Scrutiny</a></li>
</ul>
Image: Shutterstock

HOOD

What's Going On With Robinhood Markets Stock?

Rocket Lab USA, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RKLB#NASDAQ">RKLB</a>) on Thursday said it has successfully completed the Preliminary Design Review (PDR) for the Space Development Agency&#8217;s <a target="_blank" href="https://www.benzinga.com/pressreleases/25/01/b42895046/rocket-lab-on-track-to-advance-u-s-defense-capabilities-passing-major-milestone-in-development-of-" rel="noreferrer noopener">Tranche 2 Transport Layer-Beta (T2TL-Beta) program.</a>
This development marks a crucial step in Rocket Lab&#8217;s role as the prime contractor for the $515 million contract awarded in early 2024.
The contract involves the design, integration, testing, and commissioning of 18 advanced data transport satellites for the U.S. Department of Defense&#8217;s Proliferated Warfighter Space Architecture.
The PDR marks a significant step towards the detailed design phase, ensuring that Rocket Lab&#8217;s satellite design meets the mission&#8217;s rigorous requirements.
This comprehensive review covered mission architecture, vehicle space design, launch operations, and integration plans.
Read More:&nbsp;<a target="_blank" href="https://www.benzinga.com/25/01/42768507/china-slaps-export-restrictions-on-dozens-of-us-companies-boeing-lockheed-martin-general-dynamics-raytheon-affected" rel="noreferrer noopener">China&#8217;s Export Crackdown Hits Boeing, Lockheed Martin And More&nbsp;</a>
The satellites are crucial for the PWSA, a low-Earth orbit constellation designed to provide secure, low-latency communications and missile tracking for U.S. defense.
Brad Clevenger, Rocket Lab&#8217;s President and CEO of National Security, emphasized that the milestone demonstrates the company&#8217;s commitment to delivering world-class satellite solutions.
The satellites will feature Rocket Lab&#8217;s vertically integrated subsystems, providing control over costs, schedules, and quality.
According to&nbsp;<a target="_blank" href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw" rel="noreferrer noopener">Benzinga Pro</a>, RKLB stock has gained over 402% in the past year. Investors can gain exposure to the stock via&nbsp;ARK Space Exploration &amp; Innovation ETF (BATS:<a class="ticker" href="https://www.benzinga.com/stock/ARKX#BATS">ARKX</a>).
Price Action: RKLB shares closed at $27.36 on Wednesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/general/biotech/25/01/42854890/us-records-first-human-bird-flu-death-high-levels-of-respiratory-illnesses-vaccine-stocks-rally" target="_blank" rel="noreferrer noopener">US Records First Human Bird Flu Death, High Levels Of Respiratory Illnesses: Vaccine Stocks Rally </a></li>
</ul>

ARKX

RKLB

Rocket Lab Advances $515 Million Satellite Contract With Key Design Milestone: Details

Hims &amp; Hers Health Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HIMS#NYSE">HIMS</a>) has seen its stock drop 21% to $25.73 over the past month, driven by <a href="https://www.benzinga.com/trading-ideas/movers/24/12/42599094/hims-hers-health-are-falling-today-whats-going-on">regulatory updates</a> from the FDA regarding tirzepatide injection shortages. However, the stock remains up over 200% over the past year, reflecting strong earnings performance.
What To Know: The company reported impressive <a href="https://www.benzinga.com/news/earnings/24/11/41728465/hims-hers-health-reports-better-than-expected-q3-results-details">third-quarter results</a> in November, with earnings of 32 cents per share, far exceeding analyst expectations of 4 cents. Revenue rose 77% year-over-year to $401.6 million, beating estimates of $382.2 million.
Subscriber growth surged 44%, reaching 2 million, and net income soared to $75.6 million, compared to a net loss of $7.6 million last year. However, gross margins narrowed slightly to 79%, down from 83% a year ago.
CEO Andrew Dudum highlighted the company's continued momentum, noting its focus on delivering accessible, personalized care. Hims &amp; Hers raised its fiscal 2024 revenue outlook to $1.46-$1.465 billion, indicating confidence in sustained growth.
Investor sentiment has otherwise been tempered over the past month by the FDA&#8217;s resolution of the tirzepatide shortage, which may pressure demand for compounded alternatives. Despite this, ongoing shortages of other GLP-1 drugs and strong fundamentals could position Hims &amp; Hers for potential long-term success.
Read Also: <a href="https://www.benzinga.com/economics/macro-economic-events/25/01/42896114/us-2025-recession-odds-plummet-good-news-or-warning-sign">US 2025 Recession Odds Plummet: Good News Or Warning Sign?</a>
<h2 class="wp-block-heading">How To Buy HIMS Stock</h2>
Besides going to a brokerage platform to purchase a share &#8211; or fractional share &#8211; of stock, you can also gain access to shares either by buying an exchange-traded fund (ETF) that holds the stock itself, or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instrument.
For example, in Hims &amp; Hers Health&#8217;s case, it is in the Health Care sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.
According to data from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, Hims &amp; Hers has a 52-week high of $35.02 and a 52-week low of $8.14.
It closed Wednesday down more than 7% at $25.73. 
Now Read:
<ul>
<li><a href="https://www.benzinga.com/25/01/42899953/five-dead-in-los-angeles-wildfires-utilities-face-scrutiny">5 Dead, Nearly 180,000 Evacuated In Los Angeles Wildfires: California Utilities Face Scrutiny</a></li>
</ul>
Image: Shutterstock

Hims & Hers Health, Inc. Class A Common Stock

HIMS

What's Going On With Hims & Hers Health Stock?

Looking into the current session, CECO Environmental Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CECO#NASDAQ">CECO</a>) shares are trading at $31.77, after a 1.21% decrease. Over the past month, the stock fell by 2.90%, but over the past year, it actually spiked by 66.60%. With questionable short-term performance like this, and great long-term performance, long-term shareholders might want to start looking into the company's price-to-earnings ratio. 

<img src="https://www.benzinga.com/files/images/story/2025/1736446510_0.png" alt="Past Year Chart" />

<h3>Comparing CECO Environmental P/E Against Its Peers</h3>
The P/E ratio measures the current share price to the company's EPS. It is used by long-term investors to analyze the company's current performance against it's past earnings, historical data and aggregate market data for the industry or the indices, such as S&amp;P 500. A higher P/E indicates that investors expect the company to perform better in the future, and the stock is probably overvalued, but not necessarily. It also could indicate that investors are willing to pay a higher share price currently, because they expect the company to perform better in the upcoming quarters. This leads investors to also remain optimistic about rising dividends in the future. 
CECO Environmental has a lower P/E than the aggregate P/E of 101.05 of the Commercial Services &amp; Supplies industry. Ideally, one might believe that the stock might perform worse than its peers, but it's also probable that the stock is undervalued. 

<img src="https://www.benzinga.com/files/images/story/2025/1736446510_1.png" alt="Guage" />

In conclusion, the price-to-earnings ratio is a useful metric for analyzing a company's market performance, but it has its limitations. While a lower P/E can indicate that a company is undervalued, it can also suggest that shareholders do not expect future growth. Additionally, the P/E ratio should not be used in isolation, as other factors such as industry trends and business cycles can also impact a company's stock price. Therefore, investors should use the P/E ratio in conjunction with other financial metrics and qualitative analysis to make informed investment decisions.

CECO

Price Over Earnings Overview: CECO Environmental

Instil Bio files for $200M mixed securities shelf

17:04 EST Instil Bio (TIL) files $200M mixed securities shelf Published first on TheFly – the ultimate source for real-time, market-moving breaking...

Instil Bio files $200M mixed securities shelf

In a report released today, Reni Benjamin from JMP Securities reiterated a Hold rating on Instil Bio (TIL – Research Report). The company's shares ...

Instil Bio (TIL) Gets a Hold from JMP Securities

H.C. Wainwright analyst Mitchell Kapoor reiterated a Buy rating on Instil Bio (TIL – Research Report) today and set a price target of $110.00. Mitc...

Instil Bio Poised for Growth Amid Biopharmaceutical Sector Activity and Strong Financial Position

H.C. Wainwright lowered the firm's price target on Instil Bio (TIL) to $110 from $120 and keeps a Buy rating on the shares post the Q3 report. The ...

Instil Bio price target lowered to $110 from $120 at H.C. Wainwright

Merck to buy rights to Chinese cancer drug for up to $3.3B

Mitchell Kapoor, an analyst from H.C. Wainwright, reiterated the Buy rating on Instil Bio (TIL – Research Report). The associated price target rema...

Strategic Acquisitions and Market Potential Position Instil Bio's SYN-2510 as a Buy with High Growth Prospects

Instil Bio's Strategic Shift To SYN-2510: A Speculative 'Buy' Opportunity

Instil Bio ( ($TIL) ) has shared an announcement. Instil Bio, Inc., through its subsidiary Complex Therapeutics LLC, has secured an $85.6 million t...

Instil Bio Secures Loan to Refinance Facility

Jefferies upgraded Instil Bio (TIL) to Buy from Hold with a price target of $52, up from $11. Published first on TheFly – the ultimate source for r...

Instil Bio upgraded to Buy from Hold at Jefferies

BNTX

SMMT

Press Releases

Instil Bio Announces Strategic Update

Earnings

Instil Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update

Instil Bio Reports First Quarter 2024 Financial Results and Provides Corporate Update

Instil Bio and ImmuneOnco Announce License and Collaboration Agreement for Development of IMM2510, a Potentially Best-in-Class PD-L1xVEGF Bispecific Antibody, and IMM27M, a Novel Next-Generation Anti-CTLA-4 Antibody

Instil Bio Reports Second Quarter 2024 Financial Results and Provides Corporate Update

Instil Bio and ImmuneOnco Announce Global Registrational Strategy for PD-L1xVEGF Bispecific Antibody, SYN-2510/IMM2510, in Non-Small Cell Lung Cancer and Triple-Negative Breast Cancer

Comments

Instil Bio

Intérêt court

Instil Bio (NASDAQ:TIL) Stock, Rapport sur les intérêts à découvert

Les gens regardent aussi

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL